Administration Defers $1.3B To California, Pauses Hospice And Home Health Enrollments
Vice President JD Vance deferred $1.3 billion to California and CMS imposed a six-month moratorium on new hospice and home health Medicare enrollments to investigate suspected fraud.

Six-Month Freeze: CMS Blocks New Medicare Enrollments for Hospice and Home Health Agencies to Fight Fraud
Trump administration will defer $1.3B in Medicaid funds for CA

Vance Announces $1.3 Billion in Medicaid Reimbursement Deferments from California over Fraud

Dr. Oz, Vance issue six-month pause on new hospice, home health providers
Overview
On May 13 Vice President JD Vance announced the Trump administration is deferring $1.3 billion in Medicaid reimbursements to California and CMS imposed a six-month moratorium on new hospice and home health Medicare enrollments.
CMS said the six-month pause will allow targeted investigations, deployment of advanced data analytics, and accelerated removal of providers suspected of committing fraud.
California officials Gov. Gavin Newsom and Attorney General Rob Bonta criticized the moves as politically motivated, and the task force told all 50 states to show proof they are prosecuting Medicaid fraud.
CMS said it has taken action against 447 hospices and 23 home health agencies in the Los Angeles region, and officials cited roughly 450 to 800 providers nationally tied to $1.4 billion in alleged charges.
CMS will intensify targeted probes and analytics during the moratorium while Vance warned federal anti-fraud funding could be halted for states that do not aggressively prosecute, and California officials said they may challenge the actions.
Analysis
Center-leaning sources frame the story as an administration-led anti-fraud crackdown, foregrounding official statements and CBS investigative data to legitimize the moratorium. Editorial choices emphasize fraud, accountability, and state failings while omitting hospice providers’ or patient-access concerns, privileging government voices and enforcement details over due-process questions.